Supreet Chemicals

Supreet Chemicals (NEW IPO): GMP, Profit, Price & expert review

by

Supreet Chemicals Limited is a specialty chemical intermediates manufacturer serving industries such as textiles, pharmaceuticals, agro-chemicals, performance chemicals, and personal care with complex chemical products and multi-step processing capabilities

Supreet Chemicals Limited was incorporated in 1992 & currently Mr. Manjeetsingh Gurbirsingh Sarna serves as the Managing Director of the company.

Supreet Chemicals Limited has a diverse customer portfolio to 188 customers in India and 27 globally across ~14 countries. It manufactures specialty chemical intermediates including aromatic amines, sulphonamides, amino phenols, and related products for industries such as pharmaceuticals, agrochemicals, textiles and performance chemicals.

Supreet Chemicals Limited has filed its DRHP with SEBI proposing an IPO consisting entirely as a Fresh Issue of ₹ 499 Cr.

Subscription date to apply for Supreet Chemicals Limited is yet to be announced. Price band for the IPO is yet to be declared.

Check DRHP
Check IPO Allotment
Supreet Chemical Website
Issue Size:₹ 499 Cr
Fresh Issue:₹ 499 Cr
Offer for Sale:N/A
Price Range:TBA
Lot Size:TBA
GMPPending

Supreet Chemicals Limited important data points

Revenue, PAT, EBITDA

YearFiscal 2025
Networth₹ 237.21 Cr
Revenue:₹ 362.54 Cr
EBITDA₹ 78.42 Cr
EBITDA Margin:~ 21.63%
PAT₹ 51.91 Cr
PAT Margin~ 14.06%
Face Value:₹ 02

IPO important dates

Open Date:TBA
Close Date:TBA
Anchor Investor BiddingTBA
Allotment Date:TBA
Refunds & Demat CreditTBA
Tentative Listing Date:TBA

Use of Proceeds

PurposeAmount
Capital Expenditure Requirement~ ₹ 310.0 Cr
Borrowing repayment~ ₹ 65.0 Cr
Sales and Marketing~ ₹ 00 Cr
Ultra-Advanced AI Staffing Suite ₹ 00 Cr

Supreet Chemicals Limited Limited Financial Data

202320242025
Revenue (₹ Cr)₹ 312.74₹ 239.75₹ 362.54
PAT (₹ Cr)₹ 56.34₹ 25.59₹ 51.91
Asset (₹ Cr)₹ 226.09₹ 338.75₹ 519.14
Net Worth (₹ Cr)₹ 162.16₹ 186.47₹ 237.21

Supreet Chemicals Limited IPO Grey Market Premium

DateIPO PriceIPO GMPProfit per lot
25-Apr₹ –₹ –₹ –
24-Apr₹ –₹ –₹ –
23-Apr₹ –₹ –₹ –
22-Apr₹ –₹ –₹ –
21-Apr₹ –₹ –₹ –
Supreet Chemicals

Supreet Chemicals Limited IPO Pros & Cons

Strengths:

  • Strong experience with over 30+ years in specialty chemical manufacturing.
  • Diverse end-user industries (pharma, agro, textile, personal care) offering broad demand exposure.
  • Growing export footprint with international customer base in multiple regions.
  • Fresh issue proceeds focused on capacity expansion (greenfield project).
  • Backward integration strategy strengthens supply reliability and quality control.

Risks:

  • Specialty chemical market is competitive with larger established players.
  • Revenue and profitability have shown year-to-year volatility.
  • Heavily dependent on global market demand and chemical pricing cycles.
  • Expansion plans entail execution and environmental compliance risks.

Supreet Chemicals Limited
Promoters – Pre offer equity (Approx)

Promoters%Shares
Harjindersingh Jaswantsingh Sarna~ 53.37 %
Narendrakaur H. Sarna~ 16.53 %
Manjeetsingh Gurbirsingh Sarna~ 5.74 %
––
––
––

Supreet Chemicals Limited Promoters – Pre offer equity (Approx)

Application TypeLot SizeNo. of LotNo. of SharesInvestment Amount
Retail (Min)–1–₹ –
Retail (Max)–13–₹ –
HNI (Min)–14–₹ –
HNI (Max)–66–₹ –
Big HNI (Min)–67–₹ –

Lead Managers / Registrars of Supreet Chemicals Limited

Lead / Book Running Lead ManagersIIFL Capital Services Limited
Registrar (RTA)MUFG Intime India Private Limited

  • It is a Gujarat-based specialty chemical intermediates manufacturer supplying complex molecules to textiles, pharma, agro, personal care and performance chemical sectors.

  • Supreet Chemicals is raising funds via IPO to finance a greenfield manufacturing facility, repay debt and support general corporate purposes.

  • The issue size comprises entirely a Fresh Issue of up ₹ 499 Cr. It will be listed on BSE and NSE platform.

  • Key risks include raw material price volatility, competitive specialty chemical space, execution challenges in capacity expansion and concentration risks.

  • Upsides include diverse end-market demand, strong processing expertise across chemistries and expansion-driven growth potential.

  • Investors can apply through ASBA via net banking or using UPI through registered stock brokers.

For more amazing blogs click here (IPO Corner).

Leave a comment